Australia
· Delayed Price · Currency is AUD Chimeric Therapeutics Statistics
Total Valuation
ASX:CHM has a market cap or net worth of AUD 8.10 million. The enterprise value is 3.03 million.
| Market Cap | 8.10M |
| Enterprise Value | 3.03M |
Important Dates
The next estimated earnings date is Thursday, May 29, 2025.
| Earnings Date | May 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:CHM has 1.62 billion shares outstanding. The number of shares has increased by 84.50% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.62B |
| Shares Change (YoY) | +84.50% |
| Shares Change (QoQ) | +20.56% |
| Owned by Insiders (%) | 19.59% |
| Owned by Institutions (%) | 2.42% |
| Float | 1.29B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.97 |
| PB Ratio | 1.36 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.17 |
| EV / Sales | 1.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.70
| Current Ratio | 0.70 |
| Quick Ratio | 0.69 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -206.87 |
Financial Efficiency
Return on equity (ROE) is -180.09% and return on invested capital (ROIC) is -111.60%.
| Return on Equity (ROE) | -180.09% |
| Return on Assets (ROA) | -48.71% |
| Return on Invested Capital (ROIC) | -111.60% |
| Return on Capital Employed (ROCE) | -209.20% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.76% in the last 52 weeks. The beta is 1.57, so ASX:CHM's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | -82.76% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 51.55 |
| Average Volume (20 Days) | 2,951,378 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:CHM had revenue of AUD 2.04 million and -17.83 million in losses. Loss per share was -0.02.
| Revenue | 2.04M |
| Gross Profit | 2.04M |
| Operating Income | -17.68M |
| Pretax Income | -17.61M |
| Net Income | -17.83M |
| EBITDA | -16.60M |
| EBIT | -17.68M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 5.07 million in cash and n/a in debt, giving a net cash position of 5.07 million or 0.00 per share.
| Cash & Cash Equivalents | 5.07M |
| Total Debt | n/a |
| Net Cash | 5.07M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 5.94M |
| Book Value Per Share | 0.00 |
| Working Capital | -3.07M |
Cash Flow
| Operating Cash Flow | -5.51M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -866.08% |
| Pretax Margin | -862.74% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:CHM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -84.50% |
| Shareholder Yield | -84.50% |
| Earnings Yield | -220.12% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:CHM has an Altman Z-Score of -7.58. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.58 |
| Piotroski F-Score | n/a |